SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-016946
Filing Date
2023-10-27
Accepted
2023-10-27 16:05:22
Documents
13
Period of Report
2023-10-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K chrs-20231024x8k.htm   iXBRL 8-K 38581
  Complete submission text file 0001558370-23-016946.txt   166961

Data Files

Seq Description Document Type Size
2 EX-101.SCH chrs-20231024.xsd EX-101.SCH 4390
3 EX-101.DEF chrs-20231024_def.xml EX-101.DEF 3163
4 EX-101.LAB chrs-20231024_lab.xml EX-101.LAB 16022
5 EX-101.PRE chrs-20231024_pre.xml EX-101.PRE 11315
7 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20231024x8k_htm.xml XML 4951
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 231355530
SIC: 2836 Biological Products, (No Diagnostic Substances)